Brief: Theratechnologies to Focus Its Commercialization Activities on North American Territory

Theratechnologies

27/04/2022 12:36

April 27 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES TO FOCUS ITS COMMERCIALIZATION
ACTIVITIES ON
THE NORTH AMERICAN TERRITORY
    * THERATECHNOLOGIES INC - WILL CEASE ITS TROGARZO
COMMERCIALIZATION OPERATIONS IN EUROPE
    * THERATECHNOLOGIES INC - SENT A NOTICE OF TERMINATION TO
TAIMED
BIOLOGICS INC. (TAIMED) AS PER OUR CONTRACTUAL OBLIGATIONS
    * THERATECHNOLOGIES INC - WILL RETURN EUROPEAN
COMMERCIALIZATION
RIGHTS TO TROGARZO FOR TAIMED WITHIN NEXT 180 DAYS
    * THERATECHNOLOGIES INC - PRICING AND REIMBURSEMENT
CONDITIONS FOR
TROGARZO IN KEY EUROPEAN COUNTRIES WERE NOT SATISFACTORY TO CO
    * THERATECHNOLOGIES - INTEND TO HONOR REGULATORY OBLIGATIONS
VIS-À-VIS PATIENTS WHO ARE CURRENTLY RECEIVING TROGARZO OVER
REQUIRED PERIOD OF TIME
    * THERATECHNOLOGIES - WILL WORK WITH TAIMED TO EVALUATE
THEIR
OPTIONS REGARDING CONTINUED COMMERCIAL AVAILABILITY OF TROGARZO
IN EUROPE
    * THERATECHNOLOGIES INC - WILL RESTRUCTURE OUR WHOLLY-OWNED
DUBLIN-BASED SUBSIDIARY AND LET GO SOME OF OUR COLLEAGUES
    * THERATECHNOLOGIES INC - REITERATE THAT OUR REVENUE
GUIDANCE
REMAINS UNCHANGED FOR CURRENT FISCAL YEAR

Source text for Eikon:  ID:nGNX8RgwYW 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))